Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Sodium valproate SF liquid
Somatropin injection	TA188 - Human growth hormone (somatropin) for the treatment of growth failure in children (review) TA64 - Growth hormone deficiency (adults) - human growth hormone
Sotalol
Stalevo tablets		ESCA
Staloral
Sulfasalazine
Sulfasalazine		ESCA
Sulpiride tablets		ESCA
Sustanon injection
Tacrolimus 0.03% ointment (30g)	TA82 - Tacrolimus and pimecrolimus for atopic eczema

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.